Ocriplasmin Treatment for Vitreomacular Traction in Real Life: Can the Indication Spectrum Be Expanded?

Acta Ophthalmologica - United States
doi 10.1111/aos.13469
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Ocriplasmin for Treatment of Vitreomacular Traction: An Update

Ophthalmology and Therapy
Ophthalmology
2016English

Ocriplasmin for the Treatment of Vitreomacular Traction and Macular Holes: Long-Term Modelling of Clinical and Economic Value of Resolution of Traction in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Vitreomacular Traction

2016English

Pss40 - Cost-Effectiveness of Ocriplasmin for the Treatment of Vitreomacular Traction, Including When Associated With Macular Hole: A Belgian Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Vitreomacular Traction Syndrome

Einstein (São Paulo, Brazil)
Medicine
2015English

Pss26 - Cost Effectiveness of Ocriplasmin for Treatment of Symptomatic Vitreomacular Adhesion in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Vitreomacular Traction Syndrome: New Non-Surgical Treatments

Revista Mexicana de Oftalmología (English Edition)
2019English

Pars Plana Vitrectomy for Treatment-Naïve Diabetic Macular Edema With or Without Vitreomacular Traction

Canadian Journal of Ophthalmology
MedicineOphthalmology
2018English

Can Automated Treatment Plans Gain Traction in the Clinic?

Journal of Applied Clinical Medical Physics
InstrumentationNuclear MedicineRadiologyRadiationImagingMedicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy